Hospital-Acquired Infection Control In The COVID-19 Era: Transformative Forces Shaping the Hospital-Acquired Infection Control Market Landscape in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Hospital-Acquired Infection Control Industry Market Size Be by 2025?
The market concerned with preventing infections acquired within healthcare settings has experienced consistent expansion across recent years, projected to increase its valuation from 34.59 billion US dollars in 2024 to 35.75 billion US dollars the following year, exhibiting a compound annual growth rate (CAGR) of 3.4%; this upward trajectory during the past period stems from factors such as the rising challenge of antibiotic resistance, escalating public and professional cognizance, tighter governmental rules, the worldwide spread of communicable illnesses, and various patient safety drives.

What's the Long-Term Growth Forecast for the Hospital-Acquired Infection Control Market Size Through 2029?
Forecasting significant expansion, the market concerned with hospital-acquired infection control is projected to reach a valuation of $44.06 billion by 2029, expanding at a consistent annual rate of 5.4% over the projection timeframe, a surge fundamentally driven by the escalating prevalence of pathogens resistant to multiple drugs, heightened efforts in pandemic readiness, amplified systematic tracking and observation, the implementation of antimicrobial management initiatives, and greater international partnership.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

What Are the Key Growth Drivers Fueling the Hospital-Acquired Infection Control Market Expansion?
Advancing numbers of COVID-19 infections are anticipated to fuel the expansion of the hospital-acquired infection control sector in the period ahead. This viral ailment, designated as COVID-19, is attributed to the SARS-CoV-2 microbe, and its worldwide prevalence has significantly boosted the need for infection control commodities and related services within healthcare settings, emphasizing both personal cleanliness protocols and the manufacturing output of crucial medical supplies. To illustrate the scale, the World Health Organization, which is a United Nations agency headquartered in Switzerland, reported that by August 8th, 2022, the worldwide tally for confirmed COVID-19 instances had climbed to 581.6 million, thus demonstrating that the escalating infection rates are the primary catalyst behind the market's upward trajectory in hospital-acquired infection management.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7694&type=smp

What Are the Key Trends Driving Hospital-Acquired Infection Control Market Growth?
Leading firms within the sector dedicated to averting hospital-acquired infections are concentrating their efforts on pioneering technological advancements, like incorporating artificial intelligence systems aimed at the prompt identification of sepsis to ultimately boost patient recovery rates through expedited diagnosis and therapeutic initiation. An AI framework designed for sepsis detection signifies cutting-edge methodologies employing machine learning and artificial intelligence to recognize nascent indications of sepsis in individuals under care. To illustrate this progress, during April of 2024, Prenosis Inc., a medical facility situated in the United States, secured the necessary marketing approval from the FDA for its Sepsis ImmunoScore, marking it as the initial system powered by AI engineered specifically to forecast sepsis, a condition posing a grave threat that potentially precipitates serious adverse effects. This groundbreaking instrument significantly sharpens early identification capabilities by analyzing data instantaneously, thereby enabling medical practitioners to implement interventions with greater speed and efficacy. The incorporation of AI is purposefully structured to serve as a supportive mechanism for clinical personnel in their choice-making processes, rather than substituting their judgment, with the final goals being superior patient results and a decrease in overall medical expenditures.

How Is the Hospital-Acquired Infection Control Market Segmented?
The hospital-acquired infection controlmarket covered in this report is segmented -

1) By Product: Sterilizers; Disinfectors; Endoscope Reprocessors; Microbial Testing Instruments; Consumables; Disinfectants; Infection Prevention And Surveillance Software; Other Products
2) By Technology: Phenotypic Methods; Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia; Bloodstream Infections; Surgical Site Infections; Gastrointestinal Infections; Urinary Tract Infection; Other Diseases
4) By Application: Disease Testing; Drug-Resistance Testing
5) By End User: Hospitals; ICUs; Ambulatory Surgical; Diagnostic Centers; Nursing Homes; Maternity Centers; Other End Users

Subsegments:
1) By Sterilizers: Steam Sterilizers; Ethylene Oxide Sterilizers; Hydrogen Peroxide Sterilizers
2) By Disinfectors: Washer Disinfectors; Automated Disinfectors
3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors; Automated Endoscope Reprocessors
4) By Microbial Testing Instruments: Culture Systems; Rapid Microbial Testing Systems
5) By Consumables: Sterilization Wraps; Filters; Personal Protective Equipment (PPE)
6) By Disinfectants: Alcohol-based Disinfectants; Chlorine-based Disinfectants; Quaternary Ammonium Compounds
7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions; Data Management Software
8) By Other Products: Cleaning Equipment; Air Purification Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7694&type=smp

Which Companies Are Leading the Charge in Hospital-Acquired Infection Control Market Innovation?
Major companies operating in the hospital-acquired infection control market include Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton dic*kinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.

Which Regions Are Leading the Global Hospital-Acquired Infection Control Market in Revenue?
North America was the largest region in the hospital-acquired infection control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7694

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.